Evidence map›Paper›PMID 41472049›Full record

ArticleMicroorganisms2025

Diversity of CRISPR-Cas Systems Identified in Urological

Pavel V Slukin, Mikhail V Fursov, Daniil V Volkov, Angelika A Sizova, Konstantin V Detushev, Ivan A Dyatlov, Nadezhda K Fursova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pavel V SlukinState Research Center for Applied Microbiology and Biotechnology, 24 Territory "Kvartal A", 142279 Obolensk, Russia.
Mikhail V FursovState Research Center for Applied Microbiology and Biotechnology, 24 Territory "Kvartal A", 142279 Obolensk, Russia.ORCID 0000-0001-9137-9551
Daniil V VolkovState Research Center for Applied Microbiology and Biotechnology, 24 Territory "Kvartal A", 142279 Obolensk, Russia.
Angelika A SizovaState Research Center for Applied Microbiology and Biotechnology, 24 Territory "Kvartal A", 142279 Obolensk, Russia.
Konstantin V DetushevState Research Center for Applied Microbiology and Biotechnology, 24 Territory "Kvartal A", 142279 Obolensk, Russia.
Ivan A DyatlovState Research Center for Applied Microbiology and Biotechnology, 24 Territory "Kvartal A", 142279 Obolensk, Russia.
Nadezhda K FursovaState Research Center for Applied Microbiology and Biotechnology, 24 Territory "Kvartal A", 142279 Obolensk, Russia.ORCID 0000-0001-6053-2621

Funding

Ministry of Science and Higher Education of the Russian Federation 075-15-2025-525 of 30.05.2025.
6 · The paper itself

Abstract

Type I-E and I-F CRISPR-Cas systems were identified in 237

Indexed as

antimicrobial resistance genesCRISPR-Cas systemsgenetic diversityspacer sequencestype I-Etype I-Furopathogenic Escherichia coli (UPEC)virulence geneswhole-genome sequencing

Identifiers

PMID41472049
PMCPMC12736100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.